Found 0 matching trials
Efficacy and Safety of Early Use PCC in Severe Trauma
NAUncontrolled hemorrhage within 24 hours after severe trauma is the main cau...
Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII
PHASE4Patients with severe hemophilia and inhibitors can be treated effectively b...
Location
Multiple Locations
Long Term Effects of Erythrocyte Lysis
N/AIn this prospective observational trial, participants with chronic hemolysi...
Location
St. Jude Children's Research Hospital
Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients
N/AThe primary aim of this study was to describe the prevalence and time cours...
Location
Medical University of Vienna
FFP Versus PCC in Intracranial Hemorrhage
NAThe goal of this study will be to determine whether PCC confers any benefit...
Location
University of Utah Medical Center
Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis
NAPulmonary embolism, the second leading cause of death in cancer patients, i...
Location
Chu Clermont-Ferrand
Treatment of Inherited Factor VII Deficiency
N/AFVII deficiency is a rare coagulation disorder. A limited number of patient...
Location
San Salvatore Hospital
ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery
PHASE2In pediatric patients (newborns and infants weighing less than 10 kg) under...
Location
IRCCS Policlinico San Donato
Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia
N/AHeparin induced thrombocytopenia (HIT) is a kind of catastrophic thrombotic...
Location
Multiple Locations
A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects
PHASE1The purpose of this study is to assess the effect of two 4-Factor PCC formu...
Location
Multiple Locations